This independent clinical review commissioned by the Scottish Government assesses the impacts of chronic hepatitis C infection on the health and wellbeing of individuals affected by contaminated blood and blood products. The review recommends that Scottish Infected Blood Support Scheme beneficiaries should be able to self-assess regarding the effect hepatitis C has had on their life, and which level of payment they are entitled to as a result. In October 2018, the Scottish Government confirmed it would accept the recommendations of this report.
Resources
Medical professional
Around 216,000 people in the UK are living with hepatitis C so it is important that all medical professionals have access to the latest training, information and advice on hepatitis C management. Find here links to relevant materials for clinicians, nurses, GPs, prison healthcare staff and other medical professionals.
Showing 31 to 40 of 297 resources
-
Clinical Review of the Impacts of Hepatitis C: Short Life Working Group Report for the Scottish Government
Scotland Reports & Research, Strategy & Planning PDF -
HCV Action and Public Health England hepatitis C roadshow in Kent: Presentations
HCV Action and Public Health England (PHE) staged the second hepatitis C good practice roadshow of 2018 in Maidstone on 5th September, bringing together 80 people from across Kent to discuss challenges to tackling hepatitis C and share solutions. The event was attended by clinicians, nurses, commissioners, drug and alcohol service workers, prison health professionals, and others working around hepatitis C in Kent.South East Other, Strategy & Planning PDF -
Summary report: Hepatitis C good practice roadshow, Kent - September 2018
This report provides a summary of the good practice hepatitis C roadshow held by HCV Action and Public Health England in Maidstone on 5th September 2018. The report includes summaries of the workshops held on the day and attendees' reflections and pledges for action.South East Reports & Research, Strategy & Planning PDF -
Addaction Hepatitis C Strategy
Substance misuse service Addaction has produced a Hepatitis C Strategy, detailing the service's five-point plan for contributing to efforts to tackle hepatitis C.UK Strategy & Planning PDF -
Good practice case study: Edinburgh Access Practice outreach service
This HCV Action good practice case study focuses on Edinburgh Access Practice's outreach service, offering testing and treatment for hepatitis C to the homeless population. In the period from March 2014 to December 2016, of the 80 referrals received, 59 patients attended (70%) and 25 started treatment, compared with typical hospital clinical attendance rates of 30-50%. From January 2017 to June 2018 use of DAAs have enabled a further 52 patients to receive treatment at the EAP over the course of just 18 months.UK, Scotland Case study PDF -
Hepatitis C in the UK 2018 Report
Public Health England's annual 'Hepatitis C in the UK' report is the key national reporting document for hepatitis C. This is the tenth such report and follows the WHO Global Health Sector Strategy on Viral Hepatitis 2016 to 2021 and the draft action plan for the health sector response to viral hepatitis in the WHO European region. The report is structured to support UK monitoring of the Global Health Sector Strategy goals and summarises the impact of UK action plans to drive down mortality from HCV and reduce the number of new infections.UK Reports & Research, Strategy & Planning PDF -
R&D, Competition and Diffusion of Innovation in the EU: The Case of Hepatitis C
This research paper assesses the impact of (i) incentives for R&D based on providing Intellectual Property (IP) rights protection, (ii) market competition and (iii) other factors including healthcare policies on access to direct acting antivirals (DAA) for hepatitis C in Europe.UK, Rest of World Reports & Research PDF -
Signposting the Way to Elimination by 2025
The Hepatitis C Coalition is an umbrella group of leading clinicians, patient organisations, professional groups, industry and other interested parties committed to the reduction of morbidity and mortality associated with hepatitis C and its eventual elimination. This collaborative strategy builds on the release of the All-Party Parliamentary Group on Liver Health's 'Eliminating Hepatitis C in England' report and Public Health England's 'Hepatitis C in England: 2018 Report', with the aim of coordinating action by the key stakeholders involved in delivering elimination.England Reports & Research, Strategy & Planning PDF -
In Good Health: A Report following the All Party Pharmacy Group’s 2018 Inquiry into Long Term Conditions
The All Party Pharmacy Group, a parliamentary group, held an inquiry into long term conditions in 2018. The Hepatitis C Trust was invited to give evidence as part of the inquiry and this report, produced following the inquiry, highlights the need to increase testing and treatment for hepatitis C in pharmacies. Pharmacy testing for hepatitis C on the Isle of Wight is also featured as a case study.UK Reports & Research PDF -
HCV Action and Public Health England hepatitis C roadshow in Oxford: Presentations
On 7th June 2018, HCV Action and Public Health England (PHE) staged a hepatitis C good practice roadshow in Oxford. The event was designed to showcase and share best practice in the prevention, diagnosis, testing and treatment of hepatitis C, and identify specific issues and potential solutions for tackling hepatitis C in Oxford and the wider South East area.England, South East Other, Strategy & Planning PDF